Possible routes leading from Amadori product precursors to glucose-derived
protein crosslinks has been suggested by model studies examining the fate o
f the Amadori products in vitro. For instance, the Amadori product can unde
rgo dehydration to give 1,4-dideoxy-1-alkylamino-2,3-hexodiulose (AP-dione)
, which has been isolated by trapping with aminoguanidine. In a model react
ion, we selected as an AGE target the dipeptide N-alpha-Z-arg-lys. The prox
imity of the arginine and lysine residues to each other promotes stable int
ramolecular crosslink formation. Incubation of N-alpha-Z-arg-lys with IO eq
uivalents of glucose in 0.2 M phosphate buffer (pH 7.4) at 37 degrees C for
five weeks produces at least 25 distinct reaction products upon fractionat
ion of this mixture by HPLC. Each fraction was isolated, concentrated, and
analyzed for its reactivity with a polyclonal anti-AGE antibody (RU) that h
as been shown previously to recognize a class of AGEs that increase as a co
nsequence of hyperglycemia and which are inhibited from forming in human su
bjects by treatment with the advanced glycation inhibitor aminoguanidine. T
he products present within one fraction (1.5% yield) were found to block an
tibody binding in a dose-dependent fashion. Further purification of this fr
action by HPLC revealed the presence of one major (0.6% yield) immunoreacti
ve compound. Characterization of this adduct by UV, ESMS and H-1-NMR spectr
a revealed the presence of intramolecular arg-lys-imidazole crosslink. This
crosslink is non-fluorescent and acid labile and may represent an importan
t class of immunoreactive AGE-crosslinks that form in vivo.